Presentation is loading. Please wait.

Presentation is loading. Please wait.

Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD 

Similar presentations


Presentation on theme: "Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD "— Presentation transcript:

1 Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD  Journal of Pain and Symptom Management  Volume 39, Issue 6, Pages e4-e6 (June 2010) DOI: /j.jpainsymman Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions

2 Fig. 1 Incidence (%) of OM, median intensity of OM pain (VAS score 0-10) on individual day posttransplant (0=day of stem cell transplantation), and median day of TB treatment start. Journal of Pain and Symptom Management  , e4-e6DOI: ( /j.jpainsymman ) Copyright © 2010 U.S. Cancer Pain Relief Committee Terms and Conditions


Download ppt "Oropharyngeal Mucositis Pain Treatment with Transdermal Buprenorphine in Patients After Allogeneic Stem Cell Transplantation  Samuel Vokurka, MD, PhD "

Similar presentations


Ads by Google